Atlas Trials

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Clinical trial NCT02770170 · COMPLETED

Trial details

NCT number
NCT02770170
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lupus Nephritis
Start date
2016-05-16
Primary completion
2020-06-23
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.